Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
155 participants
OBSERVATIONAL
2021-05-01
2022-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Evaluate the Efficacy and Safety of Balloon Catheter Combined With Oxytocin Induction in Nulliparous Women With Estimated Fetal Weight ≥3500g at 39-40 Weeks of Gestation
NCT05197101
Induction of Labor With Oxytocin: When Should Oxytocin be Held?
NCT00957593
Inpatient and Outpatient Balloon Catheter Cervical Ripening
NCT04342741
Impact of Maternal BMI on Plasma Levels of Oxytocin During Labor Augmentation
NCT04093479
Head-perineum Distance and Delivery Mode
NCT04771091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
4 cm cervical os dilatation
Low risk women with cervical os dilatation of 4 cm at amniotomy and whether they need oxytocin augmentation and analgesia.
oxytocin augmentation
Only observation of the outcome
6 cm cervical os dilatation
Low risk women with cervical os dilatation of 6 cm at amniotomy and whether they need oxytocin augmentation and analgesia.
oxytocin augmentation
Only observation of the outcome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
oxytocin augmentation
Only observation of the outcome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no medical disorders
* no antenatal complications such as hypertension and diabetes
Exclusion Criteria
* one previous caesarean section
* other uterine scars
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National University of Malaysia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rahana Abd Rahman
Role: PRINCIPAL_INVESTIGATOR
National University of Malaysia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National University of Malaysia
Cheras, Kuala Lumpur, Malaysia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FF-2021-173
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.